Home
Press Releases
SEC Filings
Events
FAQs
Annual Reports
Fact Sheet
Management Team
Code of Ethics
Board of Directors
Stock Ownership
Contact Us

[2009 Archive] [2008 Archive] [2007 Archive] [2006 Archive] [2005 Archive] [2004 Archive] [2003 Archive] [2009_Archive]

 

 

11/08/2007--

Columbia Laboratories reports Third Quarter 2007 Financial Results

 

11/01/2007--

Columbia Laboratories to Discuss Third Quarter 2007 Financial Results on November 8, 2007 Conference Call

 

10/30/2007--

Columbia Laboratories to Present at Rodman & Renshaw Healthcare Conference in NYC on November 6, 2007

 

10/15/2007--

Vaginal Progesterone is Equally Effective and Results in Lower Miscarriage Rates Than Injectable Progesterone in Infertility Treatment

 

10/02/2007--

Vaginal Progesterone Gel May Improve Infant Outcomes and Reduce the Rate of Preterm Birth in Women with a Short Cervix in Mid-Pregnancy

 

09/27/2007--

Columbia Laboratories Signs U.S. License and Supply Agreement with Ascend Therapeutics to Market PROCHIEVE(R) 4% Progesterone Gel

 

09/25/2007--
Columbia Laboratories to Present at the UBS 2007 Global Life Sciences Conference on September 27
 

09/20/2007--
Columbia Laboratories to Present at the UBS 2007 Global Life Sciences Conference on September 27
 

09/05/2007--
Columbia Laboratories and DesignRxclusive Increase Access to CRINONE 8% Progesterone Gel for Uninsured Patients
 

08/17/2007--
Columbia Laboratories To Present At Noble Financial Two Double-O-Seven Conference On August 21
 

08/07/2007--
Columbia Laboratories Reports Second Quarter 2007 Financial Results
 

07/31/2007--
Columbia laboratories to discuss second quarter 2007 financial results on August 7 conference call
 

06/27/2007--
Columbia Laboratories Reports Positive Results from Multi-dose Pharmacokinetic Study of Vaginally-administered Lidocaine
 

06/25/2007--
Interim Analysis of CRINONE Pregnancy Study to be published in American Society for Reproductive Medicine Journal
 

06/07/2007--
Columbia Laboratories Receives Outstanding Regional Employer Award from RESOLVE: The National Infertility Association
 

05/23/2007--
Columbia Laboratories To Present At FBR Investor Growth Conference On May 31, 2007
 

05/08/2007--
Columbia Laboratories Reports First Quarter 2007 Financial Results
 

05/02/2007--
Columbia Laboratories To Present At UBS Specialty Pharmaceuticals Conference On May 9, 2007
 

05/01/2007--
Columbia Laboratories To Discuss First Quarter 2007 Financial Results On May 8, 2007 Conference Call
 

04/26/2007--
Columbia Laboratories Reports Preliminary Findings from the Ongoing Data Analysis of the Phase III Clinical Study of PROCHIEVE 8% (progesterone gel) to Prevent Preterm Birth
 

03/15/2007--
Columbia Laboratories Reports Fourth Quarter and Year-End 2006 Financial Results
 

03/07/2007--
Columbia Laboratories To Discuss Fourth Quarter And Year End 2006 Financial Results On March 15, 2007, Conference Call
 

02/26/2007--
Columbia Laboratories To Discuss Infertility Business Outlook And Strategic Plan For 2007 On March 2, 2007, Conference Call
 

02/04/2007--
Phase III Trial of Progesterone for the Prevention of Preterm Birth in Women with a Previous Preterm Birth Earlier than 35 Weeks Does Not Meet Endpoints
 

01/02/2007--
CBRX To Discuss Acquisition Of CrinoneŽ (Progesterone Gel) U.S. Marketing Rights Conference Call